Arkolith/Insider Trading/VERA/Form 4

Fordyce Marshall

PRESIDENT AND CEO, DirectorVera Therapeutics, Inc. (VERA) · full profile →Form 4 · filed Feb 27, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$547K
Net Open-Market Flow
-$547K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 26, 2025Sell(S)8K$27.55$220K206K
Feb 26, 2025Sell(S)1K$28.32$31K205K
Feb 21, 2025Sell(S)11K$27.89$296K214K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-005841) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML